Attached files
| file | filename |
|---|---|
| 10-K - Cytosorbents Corp | v180039_10k.htm |
| EX-32.1 - Cytosorbents Corp | v180039_ex32-1.htm |
| EX-31.2 - Cytosorbents Corp | v180039_ex31-2.htm |
| EX-31.1 - Cytosorbents Corp | v180039_ex31-1.htm |
CERTIFICATION
OF
CHIEF
EXECUTIVE OFFICER
AND
CHIEF FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350
In
connection with the accompanying annual report on Form 10-K of Medasorb
Technologies Corporation for the year ending December 31, 2009, I, David
Lamadrid, Chief Financial Officer of Medasorb Technologies Corporation, hereby
certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906
of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
that:
|
1.
|
Such
annual report of Form 10-K for the year ending December 31, 2009, fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
|
|
2.
|
The
information contained in such annual report of Form 10-K for the year
ending December 31, 2009, fairly represents in all material respects, the
financial condition and results of operations of Medasorb Technologies
Corporation
|
|
Date:
April 9, 2010
|
|
|
MEDASORB
TECHNOLOGIES CORPORATION
|
|
|
By:
|
/s/ David Lamadrid
|
|
David
Lamadrid
Chief
Financial Officer
|
|